Long-Term Safety Study of Canagliflozin (TA-7284) in Combination With GLP-1 Analogue in Patients With Type 2 Diabetes Mellitus
Clinical trial NCT02227849 · COMPLETED
Trial details
- NCT number
- NCT02227849
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-01
- Primary completion
- 2016-03-01
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.